<code id='A8CD248D2B'></code><style id='A8CD248D2B'></style>
    • <acronym id='A8CD248D2B'></acronym>
      <center id='A8CD248D2B'><center id='A8CD248D2B'><tfoot id='A8CD248D2B'></tfoot></center><abbr id='A8CD248D2B'><dir id='A8CD248D2B'><tfoot id='A8CD248D2B'></tfoot><noframes id='A8CD248D2B'>

    • <optgroup id='A8CD248D2B'><strike id='A8CD248D2B'><sup id='A8CD248D2B'></sup></strike><code id='A8CD248D2B'></code></optgroup>
        1. <b id='A8CD248D2B'><label id='A8CD248D2B'><select id='A8CD248D2B'><dt id='A8CD248D2B'><span id='A8CD248D2B'></span></dt></select></label></b><u id='A8CD248D2B'></u>
          <i id='A8CD248D2B'><strike id='A8CD248D2B'><tt id='A8CD248D2B'><pre id='A8CD248D2B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:371
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          Grail is spending more than ever lobbying Congress
          Grail is spending more than ever lobbying Congress

          GrailGrailspentmorethan$1millionlastquarterlobbyingCongress,underscoringtheurgencyofthecompany’sbidt

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Diverse clinical trials: Why aren’t we there yet?

          KeishaOkaforforSTATClinicaltrialsarecriticaltoadvancinglifesavingmedicationsandtreatments.ButtheU.S.